Spinal glycine transporter-1 inhibition influences the micturition reflex in urethane-anesthetized rats.
Spinal glycine transporter-1 inhibition influences the micturition reflex in urethane-anesthetized rats.
复制标题
脊髓甘氨酸转运蛋白 1 抑制影响尿烷麻醉大鼠的排尿反射。
DOI:
10.1007/s11255-015-1148-0
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Takenaka A
中科院分区:
文献类型:
--
作者:
Honda M;Hikita K;Kawamoto B;Muraoka K;Shimizu S;Saito M;Sejima T;Chancellor MB;Yoshimura N;Takenaka A
PurposeGlycine is an inhibitory neurotransmitter in the central nervous system. So far, two types of glycine transporters (GlyTs), GlyT-1 and GlyT-2, have been cloned. The aim of this study is to investigate the effects of a selective GlyT-1 inhibitor that can increase endogenous glycine concentration on the micturition reflex in urethane-anesthetized rats.MethodsContinuous cystometrograms (0.04 ml/min) were performed in female Sprague–Dawley rats (232–265 g) under urethane anesthesia. After stable micturition cycles were established, ALX5407, a selective GlyT-1 inhibitor, was administered intrathecally or intracerebroventricularly to evaluate changes in bladder activity. Cystometric parameters were recorded and compared before and after drug administration.ResultsIntrathecal administration of ALX5407 (1, 3, 10 and 30 μg) increased intercontraction intervals at doses of 3 μg or higher in a dose-dependent fashion. Intrathecal administration of ALX5407 (1, 3, 10 and 30 μg) also increased pressure threshold at doses of 3 μg or higher in a dose-dependent fashion. However, when ALX5407 (1, 3, 10 and 30 μg) was administered intracerebroventricularly, there were no significant changes in intercontraction intervals, pressure threshold, maximum voiding pressure or baseline pressure or post-void residual urine volume at any doses tested.ConclusionThe results of our study indicate that GlyT-1 plays an important role in the modulation of micturition. Furthermore, these findings indicate that in urethane-anesthetized rats suppression of GlyT-1 can inhibit the micturition reflex at the spinal cord level. Thus, GlyT-1 could be a potential target for the treatment of bladder dysfunction such as overactive bladder.